Literature DB >> 22233309

Community-acquired Burkholderia cepacia pneumonia: a report of two immunocompetent patients.

Mehmet Bayram1, Mesiha Babalık, Nur Dilek Bakan, Isa Döngel.   

Abstract

Burkholderia cepacia is a gram-negative bacilli leading to pneumonia with poor prognosis and usually seen in patients with immunosuppression or with structural lung diseases. This report is about two patients with no underlying disease diagnosed as B. cepacia pneumonia mimicking malignancy and tuberculosis. Bronchoscopy was applied on both patients since no response to treatment with wide spectrum antibiotics and negative sputum smears for acid-fast bacili. B. cepacia was isolated from bronchial lavage culture. Antibiogram revealed sensitivity to quinolones in both cases. Radiological and clinical complete remission was seen in patients by quinolones. The current cases showed that community-acquired Burkholderia pneumonia is possible in healthy patients. Bronchial washing is important in diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22233309     DOI: 10.5578/tt.1159

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  4 in total

1.  Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis.

Authors:  Charles Nc Hua; Jinichi Tokeshi
Journal:  Hawaii J Med Public Health       Date:  2013-09

2.  Case Report: Community-Acquired Burkholderia cepacia Pneumonia of a Patient with Pulmonary Tuberculosis.

Authors:  Qiang Li; Li-Ping Ma
Journal:  Am J Trop Med Hyg       Date:  2022-06-13       Impact factor: 3.707

3.  Community Acquired Burkholderia cepacia Bacteraemia Presenting as MODS in an Immunocompetent Individual: An Unusual Case.

Authors:  Ritesh Ranjan; Priti Chowdhary; Aman Kamra
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Multidrug-resistant Burkholderia cepacia bacteremia in an immunocompetent adult diagnosed with dengue and scrub coinfection: A rare case report.

Authors:  Sai Saran; Afzal Azim; Mohan Gurjar
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.